An overview of state (Tennessee) and county-level adolescent substance use data to include a summary of TN Together adolescent survey results from 2018/2019.
This document summarizes the national perspective on prescription drug abuse in the United States. It outlines the federal government's Prescription Drug Abuse Prevention Plan, which takes a coordinated approach across four focus areas: education, prescription drug monitoring programs, proper medication disposal, and enforcement. The document also provides some statistics showing signs of progress in reducing prescription drug abuse, such as decreases in the number of Americans initiating nonmedical use of prescription opioids and in the rates of past year use among high school seniors of certain opioids. However, it notes that long-term success will require ongoing coordination across government levels.
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
This document discusses patient review and restriction programs (PRRs) as tools to help curb prescription drug abuse and coordinate patient care. It describes state Medicaid PRR programs and recent efforts to expand PRR programs to Medicare. It also describes the role of PRR programs in the CDC's Prescription Drug Overdose Prevention for States grant program, the Office of National Drug Control Policy's national strategy, and the federal budget.
This document summarizes a presentation on insights from state policies and interventions to curb prescription drug overdoses. It describes several interventions:
1) PRIMUM, a system in North Carolina that alerts prescribers to patients' risk of misusing or abusing opioids at the point of care.
2) A project in Rhode Island that developed protocols to improve opioid prescription safety for trauma patients, including alerts if prescriptions exceed dosage thresholds and requiring naloxone co-prescriptions.
3) A study in Pennsylvania that used Medicaid claims data to identify risk factors for opioid overdoses, such as high dosage and multiple prescribers/pharmacies, to target high-risk patients.
The document summarizes a vision session on prescription opioid overdose that included presentations from the Oklahoma Commissioner of Health and the president of ASTHO. Key points discussed include:
- The growing epidemic of prescription opioid overdose deaths and costs to the healthcare system.
- ASTHO's Prescription Drug Overdose Prevention Challenge which aims to reduce overdose rates and engages state health officials and partners across sectors.
- Strategies discussed to address the epidemic through prevention, monitoring, enforcement, treatment and recovery efforts.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Presentation by Roumen Sedefov (European Monitoring Center for Drug and Drug Addictions (EMCDDA)) on the occasion of the EESC hearing on New Psychoactive Substances (Brussels, 27 November 2013)
This document summarizes the national perspective on prescription drug abuse in the United States. It outlines the federal government's Prescription Drug Abuse Prevention Plan, which takes a coordinated approach across four focus areas: education, prescription drug monitoring programs, proper medication disposal, and enforcement. The document also provides some statistics showing signs of progress in reducing prescription drug abuse, such as decreases in the number of Americans initiating nonmedical use of prescription opioids and in the rates of past year use among high school seniors of certain opioids. However, it notes that long-term success will require ongoing coordination across government levels.
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
This document discusses patient review and restriction programs (PRRs) as tools to help curb prescription drug abuse and coordinate patient care. It describes state Medicaid PRR programs and recent efforts to expand PRR programs to Medicare. It also describes the role of PRR programs in the CDC's Prescription Drug Overdose Prevention for States grant program, the Office of National Drug Control Policy's national strategy, and the federal budget.
This document summarizes a presentation on insights from state policies and interventions to curb prescription drug overdoses. It describes several interventions:
1) PRIMUM, a system in North Carolina that alerts prescribers to patients' risk of misusing or abusing opioids at the point of care.
2) A project in Rhode Island that developed protocols to improve opioid prescription safety for trauma patients, including alerts if prescriptions exceed dosage thresholds and requiring naloxone co-prescriptions.
3) A study in Pennsylvania that used Medicaid claims data to identify risk factors for opioid overdoses, such as high dosage and multiple prescribers/pharmacies, to target high-risk patients.
The document summarizes a vision session on prescription opioid overdose that included presentations from the Oklahoma Commissioner of Health and the president of ASTHO. Key points discussed include:
- The growing epidemic of prescription opioid overdose deaths and costs to the healthcare system.
- ASTHO's Prescription Drug Overdose Prevention Challenge which aims to reduce overdose rates and engages state health officials and partners across sectors.
- Strategies discussed to address the epidemic through prevention, monitoring, enforcement, treatment and recovery efforts.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Presentation by Roumen Sedefov (European Monitoring Center for Drug and Drug Addictions (EMCDDA)) on the occasion of the EESC hearing on New Psychoactive Substances (Brussels, 27 November 2013)
We honor ourselves when we speak out for recovery. We show the world that recovery matters because it brings hope and peace into the lives of individuals and their loved ones. ~ Beth Wilson
The only person you are destined to become is the person you decide to be. ~ Ralph Waldo Emerson
Success is the sum of small efforts, repeated day in and day out.
~ Robert Collier
Presentation by Péter Sárosi (Civil Society Forum on Drugs) on the occasion of the EESC hearing on New Psychoactive Substances (Brussels, 27 November 2013)
Total global spending on medicines will exceed $1.2 trillion in 2017, an increase of $205-235 billion from 2012. The key countries of the US, EU5, Japan, and China will account for 67% of global spending in 2017, contributing 59% of growth. The mix of spending will shift toward generics, rising from 27% to 36% of total spending by 2017. Current pharmaceutical research holds potential to transform disease treatment across many areas, such as new oral drugs for rheumatoid arthritis and advances in cancer treatment. However, more research is still needed for diseases that have a high global burden, such as malaria, in emerging markets.
The document summarizes key findings from the UNODC's World Drug Report 2016. It finds that while the number of women arrested for drug offenses has increased, the proportion of women in drug cases has decreased. It also discusses trends in drug production, use, and related health issues. Additionally, it examines the relationship between development levels, socioeconomic status, and drug use. The report concludes that development initiatives and responses to drug problems must work in tandem to be effective and minimize unintended impacts. Drug policies should be evidence-based, sensitive to vulnerable groups, and aim to reduce stigma and imprisonment for minor drug offenses.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Preventing teen abuse of prescriptions and over theraynaandyailka
This document discusses preventing teen abuse of prescription and over-the-counter medications. It outlines a mission and goals to educate stakeholders on risk factors for teen abuse and significantly reduce abuse among teens aged 13-19. Objectives include better understanding trends in teen medication abuse, increasing parent-teen communication, and reducing unattended medications. Statistics show increasing rates of teen prescription drug abuse. Efforts to address the issue include prescription drug monitoring programs, take-back initiatives, and educating parents, physicians, and communities. Challenges include getting families, physicians, and authorities adequately involved in prevention.
This document summarizes a panel discussion on improving utilization of prescription drug monitoring programs (PDMPs). The panel will discuss current practices for interstate sharing of PDMP data, strategies for integrating PDMP data into healthcare records, and lessons from Washington state's program providing organizations access to PDMP data. The goal is to identify best practices that can be implemented in other states to increase interoperability and utilization of PDMP data.
Rx16 federal tues_200_1_gladden_2halpin_3greenOPUNITE
This document provides information about the emerging fentanyl overdose epidemic in the United States from the national and state perspectives. It discusses the rise in fentanyl-related overdoses and seizures from 2013-2014 according to data from various sources. The learning objectives are to explain the epidemiology of the rise in fentanyl overdoses, identify lessons from an Ohio investigation, and describe one state's experience. Recommendations include improving detection of fentanyl through testing and surveillance, expanding naloxone access, and long-term efforts to reduce opioid overdoses through prescribing guidelines and treatment expansion.
'Legal Highs or Legal Killers' Conference PresentationsMentor
Mentor lead the conference 'Legal Highs or Legal Killers? Tackling the spread of New Psychoactive Substances' on 18th September 2014.
Its aim was to bring together a wide range of professionals to:
raise awareness of the nature and potential harms of NPS
understand where to find useful resources
get up-to-date on government approach to NPS, and to the current status of substance misuse law, and laws and guidance affecting trading standards
look at options for prevention and for building resilience in young people
assess options for tackling the marketing and sale of NPS, and the most effective role for the criminal justice system
This slideshare gives presentations from nearly all the speakers who were present.
For more details, head to http://www.mentoruk.org/2014/10/legal-highs-conference/.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
This document summarizes opioid prescribing trends, policies, and their impacts in Canada and at the US-Canada border. It finds that while Canada and the US have high opioid consumption, Canadian policies like introducing tamper-deterrent OxyContin and a prescription monitoring program reduced potentially inappropriate prescribing by 1%. However, over 1 million such prescriptions remain, and inconsistencies in provincial policies and lack of prescriber access to prescription data limit the policies. The approval of generic long-acting oxycodone in Canada did not increase trafficking into the US, though losses cannot be tracked. Ongoing evaluation is needed to improve policies around opioid availability and curb misuse across the border.
This document summarizes substance abuse issues faced in emergency departments. It notes that substance abuse patients are frequent emergency department users who require significant resources. Over 5 million emergency department visits annually are related to drugs, including 2.5 million specifically for drug abuse or misuse. Prescription opioid abuse and overdoses have risen dramatically in recent years. New CDC guidelines aim to curb opioid prescribing practices to help address this crisis. Emergency physicians are on the front lines of this issue and see the consequences of opioid addiction firsthand.
This document discusses using federal and state survey data to inform state health reform. It outlines key federal surveys such as the American Community Survey, Current Population Survey, and Behavioral Risk Factor Surveillance System. While some provide state-level estimates, sample sizes vary significantly across states. Strategies are presented to increase the value of these surveys for states, such as expanding content and timely release of data. State-specific surveys are also proposed to address gaps in measuring outcomes like access, costs, and quality of care. In the end, both federal and state surveys will be important for analyzing health reform impacts, but may lack data on important subgroups and outcomes.
This document discusses ensuring access to quality substance use disorder (SUD) treatment. It outlines federal laws like the Mental Health Parity and Addiction Equity Act and Affordable Care Act that are intended to improve access to SUD treatment. It also discusses some state parity laws. While progress has been made in expanding coverage for SUD treatment, barriers still exist like limits on services and lack of providers. Enforcement of these laws is needed to fully achieve parity and reduce denials of medically necessary care.
Cannabis Science & Policy Summit - Day 2 - NovakCannabisSummit
This document summarizes a study that used latent class analysis to identify patterns of medical cannabis consumption among 50 patients in San Francisco. The analysis identified 4 classes: pure therapy (10%), pure euphoria (10%), mixed motives (55%), and smoked euphoria (25%). Characteristics like gender, medical conditions, and socioeconomic status were associated with class membership. Probability of consumption varied by day of week and payday cycles, with higher use on weekends and paydays. The findings suggest medical cannabis is used more for euphoria than purely medical reasons for most patients.
Opioid Epidemic - Causes, Impact and FutureCitiusTech
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
We honor ourselves when we speak out for recovery. We show the world that recovery matters because it brings hope and peace into the lives of individuals and their loved ones. ~ Beth Wilson
The only person you are destined to become is the person you decide to be. ~ Ralph Waldo Emerson
Success is the sum of small efforts, repeated day in and day out.
~ Robert Collier
Presentation by Péter Sárosi (Civil Society Forum on Drugs) on the occasion of the EESC hearing on New Psychoactive Substances (Brussels, 27 November 2013)
Total global spending on medicines will exceed $1.2 trillion in 2017, an increase of $205-235 billion from 2012. The key countries of the US, EU5, Japan, and China will account for 67% of global spending in 2017, contributing 59% of growth. The mix of spending will shift toward generics, rising from 27% to 36% of total spending by 2017. Current pharmaceutical research holds potential to transform disease treatment across many areas, such as new oral drugs for rheumatoid arthritis and advances in cancer treatment. However, more research is still needed for diseases that have a high global burden, such as malaria, in emerging markets.
The document summarizes key findings from the UNODC's World Drug Report 2016. It finds that while the number of women arrested for drug offenses has increased, the proportion of women in drug cases has decreased. It also discusses trends in drug production, use, and related health issues. Additionally, it examines the relationship between development levels, socioeconomic status, and drug use. The report concludes that development initiatives and responses to drug problems must work in tandem to be effective and minimize unintended impacts. Drug policies should be evidence-based, sensitive to vulnerable groups, and aim to reduce stigma and imprisonment for minor drug offenses.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Preventing teen abuse of prescriptions and over theraynaandyailka
This document discusses preventing teen abuse of prescription and over-the-counter medications. It outlines a mission and goals to educate stakeholders on risk factors for teen abuse and significantly reduce abuse among teens aged 13-19. Objectives include better understanding trends in teen medication abuse, increasing parent-teen communication, and reducing unattended medications. Statistics show increasing rates of teen prescription drug abuse. Efforts to address the issue include prescription drug monitoring programs, take-back initiatives, and educating parents, physicians, and communities. Challenges include getting families, physicians, and authorities adequately involved in prevention.
This document summarizes a panel discussion on improving utilization of prescription drug monitoring programs (PDMPs). The panel will discuss current practices for interstate sharing of PDMP data, strategies for integrating PDMP data into healthcare records, and lessons from Washington state's program providing organizations access to PDMP data. The goal is to identify best practices that can be implemented in other states to increase interoperability and utilization of PDMP data.
Rx16 federal tues_200_1_gladden_2halpin_3greenOPUNITE
This document provides information about the emerging fentanyl overdose epidemic in the United States from the national and state perspectives. It discusses the rise in fentanyl-related overdoses and seizures from 2013-2014 according to data from various sources. The learning objectives are to explain the epidemiology of the rise in fentanyl overdoses, identify lessons from an Ohio investigation, and describe one state's experience. Recommendations include improving detection of fentanyl through testing and surveillance, expanding naloxone access, and long-term efforts to reduce opioid overdoses through prescribing guidelines and treatment expansion.
'Legal Highs or Legal Killers' Conference PresentationsMentor
Mentor lead the conference 'Legal Highs or Legal Killers? Tackling the spread of New Psychoactive Substances' on 18th September 2014.
Its aim was to bring together a wide range of professionals to:
raise awareness of the nature and potential harms of NPS
understand where to find useful resources
get up-to-date on government approach to NPS, and to the current status of substance misuse law, and laws and guidance affecting trading standards
look at options for prevention and for building resilience in young people
assess options for tackling the marketing and sale of NPS, and the most effective role for the criminal justice system
This slideshare gives presentations from nearly all the speakers who were present.
For more details, head to http://www.mentoruk.org/2014/10/legal-highs-conference/.
This document discusses the use of poison center data to track trends in prescription drug abuse and overdoses. It shows that between 1999-2011, prescription opioid exposures reported to poison centers increased over 150% in the US and 164% in Kentucky. Specific opioids like oxycodone, hydrocodone, and tramadol also increased substantially. Poison center data can provide real-time surveillance to identify emerging problems and formulate strategies to address them.
This document summarizes opioid prescribing trends, policies, and their impacts in Canada and at the US-Canada border. It finds that while Canada and the US have high opioid consumption, Canadian policies like introducing tamper-deterrent OxyContin and a prescription monitoring program reduced potentially inappropriate prescribing by 1%. However, over 1 million such prescriptions remain, and inconsistencies in provincial policies and lack of prescriber access to prescription data limit the policies. The approval of generic long-acting oxycodone in Canada did not increase trafficking into the US, though losses cannot be tracked. Ongoing evaluation is needed to improve policies around opioid availability and curb misuse across the border.
This document summarizes substance abuse issues faced in emergency departments. It notes that substance abuse patients are frequent emergency department users who require significant resources. Over 5 million emergency department visits annually are related to drugs, including 2.5 million specifically for drug abuse or misuse. Prescription opioid abuse and overdoses have risen dramatically in recent years. New CDC guidelines aim to curb opioid prescribing practices to help address this crisis. Emergency physicians are on the front lines of this issue and see the consequences of opioid addiction firsthand.
This document discusses using federal and state survey data to inform state health reform. It outlines key federal surveys such as the American Community Survey, Current Population Survey, and Behavioral Risk Factor Surveillance System. While some provide state-level estimates, sample sizes vary significantly across states. Strategies are presented to increase the value of these surveys for states, such as expanding content and timely release of data. State-specific surveys are also proposed to address gaps in measuring outcomes like access, costs, and quality of care. In the end, both federal and state surveys will be important for analyzing health reform impacts, but may lack data on important subgroups and outcomes.
This document discusses ensuring access to quality substance use disorder (SUD) treatment. It outlines federal laws like the Mental Health Parity and Addiction Equity Act and Affordable Care Act that are intended to improve access to SUD treatment. It also discusses some state parity laws. While progress has been made in expanding coverage for SUD treatment, barriers still exist like limits on services and lack of providers. Enforcement of these laws is needed to fully achieve parity and reduce denials of medically necessary care.
Cannabis Science & Policy Summit - Day 2 - NovakCannabisSummit
This document summarizes a study that used latent class analysis to identify patterns of medical cannabis consumption among 50 patients in San Francisco. The analysis identified 4 classes: pure therapy (10%), pure euphoria (10%), mixed motives (55%), and smoked euphoria (25%). Characteristics like gender, medical conditions, and socioeconomic status were associated with class membership. Probability of consumption varied by day of week and payday cycles, with higher use on weekends and paydays. The findings suggest medical cannabis is used more for euphoria than purely medical reasons for most patients.
Opioid Epidemic - Causes, Impact and FutureCitiusTech
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
1) The document discusses substance use disorders and related topics from Healthy People 2020, including goals to increase quality of life and eliminate health disparities, with a focus on mental health and substance abuse.
2) Key details are provided on substance abuse objectives from Healthy People 2020, federal agencies and national institutes involved in substance abuse treatment and research, common drugs of abuse, and diagnostic criteria for substance use disorders.
3) Statistics are presented on prevalence of substance use disorders in the US and high-risk groups like college students and military/veterans. Etiology, neurobiology, screening and assessment tools, physical exam findings, and stages of change are summarized.
Prescription opioid use among adults with mental health disorders in the US.Paul Coelho, MD
This study analyzed nationally representative health survey data to examine prescription opioid use among US adults with mental health disorders. The key findings were:
1) An estimated 18.7% of the 38.6 million American adults with mental health disorders use prescription opioids, accounting for 51.4% of the total opioid prescriptions distributed in the US each year.
2) Adults with mental health disorders were over 3 times more likely to use opioids compared to adults without mental health disorders.
3) Having a mental health disorder was associated with a more than 2 times greater odds of prescription opioid use after adjusting for other health factors.
Prescription Opioid Use Among Adults with Mental Health Disorders in the USPaul Coelho, MD
This study used nationally representative survey data to examine prescription opioid use among US adults with mental health disorders. The key findings were:
1) An estimated 18.7% of the 38.6 million American adults with mental health disorders use prescription opioids, accounting for 51.4% of the total opioid prescriptions distributed in the US each year.
2) Adults with mental health disorders were over 3 times more likely to use opioids compared to adults without mental health disorders.
3) Having a mental health disorder, such as depression or anxiety, was associated with a more than 2 times greater odds of prescription opioid use after adjusting for other factors.
1Joseph Role of Opioid Education for the YouthEsther Joscargillfilberto
This document discusses the role of opioid education for youth. It finds that educating youth about opioids can help reduce misuse by making them aware of the risks of addiction and overdose. However, media coverage of opioids may also increase curiosity and accidental exposure. While prevention programs show promise, limitations include the possibility that education increases initial curiosity about drugs. Overall, early intervention through education may help delay first-time use and reduce health risks for youth.
Intro to Prevention: Psychopharmacology Guest LectureJulie Hynes
Current A&D Conditions in lane County: And why we need prevention. Guest lecturer: Julie Hynes, MA, RD, CPS - PreventionLane at Lane County Public Health
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™
This document summarizes the growing problem of prescription drug abuse in America. Key points include:
- Prescription drug abuse is now the nation's fastest growing drug problem, with opioids like oxycodone being abused at increasing rates.
- Education of healthcare providers, patients, and the public is needed to increase awareness of the dangers of prescription drug misuse and how to properly use and dispose of medications.
- Tracking programs like prescription drug monitoring programs (PDMPs) in states can help identify "doctor shoppers" and reduce diversion, though more research is still needed on their effectiveness.
- A multifaceted approach including education, monitoring, safe disposal, and enforcement is needed to address the crisis of prescription drug
This document discusses health awareness initiatives and provides definitions for key related terms:
- It defines health as a state of complete physical, mental and social well-being, not just the absence of disease.
- It then provides definitions for 3 terms: ability to assess and initiate independently, awareness of situations/facts, and drug dependence.
- The last paragraph summarizes that the document discusses health awareness initiatives and defines several related terms.
Methadone is commonly used to treat opioid addiction through maintenance therapy or detoxification. Methadone maintenance involves long-term administration of methadone to reduce withdrawal symptoms and drug cravings without producing euphoria. Studies show methadone maintenance is more effective at treating heroin addiction than short-term detoxification programs due to lower relapse rates and reduced criminal behavior.
The document summarizes key points from a presentation given by Pamela S. Hyde, Administrator of SAMHSA, at an annual research conference on September 2, 2010. Some of the main topics discussed include challenges facing adolescents with substance abuse issues, dramatic shifts in substance abuse treatment for pregnant teens, the prevalence of mental illness in America and its links to other health issues, and strategic initiatives being undertaken by SAMHSA to address issues like prevention, trauma, military families, and health insurance reform.
This document provides information about substance misuse, including harmful effects on individuals and society. It identifies sources of help for substance misuse and sources of information about drug use rates. The document also discusses government policy approaches to substance misuse, which include legal controls, treatment options, and preventative education. It provides statistics about illicit drug use in England and Wales from the Crime Survey and poses discussion questions.
Techniques of treatment on drug addicted people in sover life rehab centerNafiz Al Kalam
No nation on earth is untouched by the effects of drug abuse. The problem has reached such a
proportion that it has become a global threat. From the impoverished villages where drugs are
grown to the modern cities where they are ultimately sold, drugs follow a complex route that hits every country in the world; Bangladesh is no exception.
This document provides an overview of a conference on chronic pain and addiction that will take place from April 10-12, 2012 at Walt Disney World Swan Resort. The conference will focus on prescription drug abuse in the US, the effects of prescription pain medication abuse over time, and advocating for continued education on addiction for pain management providers. Key statistics on prescription drug abuse in the US are presented, including that opioid analgesics are now the leading cause of accidental drug overdose deaths. Abuse of prescription drugs is rising among both adolescents and older adults.
The document discusses methodological challenges in analyzing safety data from clinical trials. It summarizes that randomized controlled trials have limited power to detect rare adverse events. Other challenges include lack of ascertainment of all adverse events and limited generalizability. Potential solutions proposed are evaluating data from different sources using appropriate statistical methods, assessing missing data, and independent evaluation of drug safety through regulatory and academic partnerships.
The chapter discusses drugs and delinquency among youth. It finds that most drug use is experimental and involves alcohol, tobacco, and marijuana. The relationship between drug use and delinquency is complex, with evidence that drug use can both cause and result from delinquency. Effective interventions include life skills training to prevent drug use and treatment programs that combine legal action with individualized treatment plans, such as drug courts.
Prescription Drug Abuse Among College Students Luis Rodriguez
This document provides an overview of a research paper on prescription drug abuse among college students. The paper includes an introduction describing the problem of increasing prescription drug abuse rates among college students. A literature review section summarizes previous research finding high rates of non-medical prescription drug use and motives for use among college students. The purpose, research question, sample, data collection methods and limitations of the study are also outlined. Key terms are defined for the purpose of the paper.
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxglendar3
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
Running head OPIOID CRISIS PUBLIC POLICY PAPER .docxtodd581
Running head: OPIOID CRISIS PUBLIC POLICY PAPER 1
OPIOID CRISIS PUBLIC POLICY PAPER 7
Opioid Crisis Public Policy Paper
Anniesha Overton
Strayer Umiversity
Summary of the policy
The opioid crisis has been a significant public health concern in the United States since the late 1990s. The inability to develop strategic legislation and regulation to control the use of opioid has been critical to the development of the opioid crisis. The opioid crisis involves the use of both prescription and non-prescription opioid drugs. According to the Center for Disease control and prevention, the rate of opioid addiction has been significantly increasing over the years. From 1999 to 2016, at least 350,000 individuals have died from related opioid addiction, which includes prescription and illicit opioids.
Unlicensed pharmacies and overdependence on these drugs in pain management have been major concepts, which have created a challenging setting where the abuse of prescription drugs can be controlled. The underlying basis of this problem is the current assumption in the United States that medical practitioners can cure almost everything. Even though it is essential to understand that prescription drugs are effective in pain management, the drugs are required to be offered based on the prescriptions issued (McDonald & Lambert, 2016). It is also noted that they should not be used regularly since they created a very detrimental habit to patient wellbeing because they have addictive properties, which make it dangerous when consumed in large portions.
Confronting opioid addiction requires significant efforts by all stakeholders in healthcare in ensuring that there is a common objective in providing that there is a crucial focus in integrating quality focus in preventing opioid addiction. Considering the fact that a prescribed drug mainly propagates opioid addiction. It is essential to ensure that they are issued through consideration of critical healthcare knowledge regarding the admissibility of opioid drugs (Bihel, 2016). Nurses have a significant role to play regarding the overall development of the opioid addiction crisis. Critical issues that have been identified in opioid drug abuse include improper use, lack of the required knowledge and related interpretation in the use of opioid prescribed drugs and decreased regulation and legislation from the government regarding the existing concern on the increasing addiction levels across the country.
Players
The increase in opioid crisis has had a direct and indirect influence on different stakeholders. Therefore developing a strong focus on essential strategies that can help limit the overall impact of the opioid crisis on the lives of an individual is critical. The national institute on drug abuse reported that in 2015, 33,091 deaths were reported be.
Similar to TRAINING 2 Unpacking Tennessee Adolescent Substance Misuse Data (20)
This document discusses strategies for following a healthful diet in order to maximize one's endurance and potential. It recommends regularly eating a variety of nourishing foods from all major food groups, which provide nutrients that support overall health and well-being. Specific tips include planning meals and snacks in advance, choosing convenient yet nutritious options, staying hydrated, and setting achievable dietary goals. The overall message is that a balanced diet through both food and lifestyle choices can help maintain health and reduce chronic disease risk.
The document discusses the importance of total farmer health, including body, mind, and spirit. It provides information on how to maximize endurance and potential through proper movement, rest, nutrition, and stress management. The presentation aims to teach farmers how to incorporate wellness into daily routines to extend their ability to work and engage in meaningful activities over the long term.
FFHW: You Are Not Alone: Taking Care of Your Mental HealthKarenChenoaSergent
The document discusses signs and symptoms of stress and provides strategies for managing stress. It notes that stress can increase impulsivity, reactivity, and physical responses while decreasing rational thinking and decision making. The document encourages recognizing signs of stress and assessing stress levels periodically. It provides a list of stress management tools that include exercise, hobbies, humor, and social support. Finally, it discusses the importance of acknowledging stress, resetting oneself, and asking for help from others or resources like crisis hotlines.
This document provides information on protective practices to prevent sun damage and skin cancer. It discusses beliefs about sun protection, recommendations including avoiding sun exposure between 10AM and 4PM, wearing protective clothing such as hats and sunglasses, and applying broad spectrum sunscreen with SPF 30 or higher. It also outlines risk factors for skin cancer like being a farmer or having fair skin, and signs of skin cancers like moles that change shape or color. Regular skin self-exams and annual checks with a healthcare provider are recommended for skin cancer screening.
Planning Today for Tomorrow's Farms (publication ) – presented as part of Session 3 of the Tennessee Master Farm Family Health and Wellness Program: "Family Relationships on the Farm "
Preventing Chronic Health Conditions in Farming PopulationsKarenChenoaSergent
By Paul Norrad, DrPH RN presentation for UT Extension and Family Consumer Sciences Tennessee Farm Family Health and Wellness Program Session 2 Health Issues Affecting Farm Families Jan 20, 2022
Session 3 A Guide to Addressing Substance Misuse in Your CommunityKarenChenoaSergent
In this session, we provide practical steps you can take in your professional role to support the development of healthy, recovery-friendly communities.
The document summarizes the key recommendations and guidelines from the 2020-2025 Dietary Guidelines for Americans. It provides guidance on healthy eating across the lifespan from infancy through older adulthood. Some of the main recommendations include exclusively breastfeeding infants for the first 6 months, introducing complementary foods at 6 months, meeting nutrient needs and maintaining a healthy weight from ages 1-2 and beyond, focusing on nutrient-dense foods from the major food groups while staying within calorie limits, and limiting added sugars, saturated fat, sodium and alcoholic beverages. The document also provides resources and tips to help customize eating patterns based on preferences, traditions and budgets.
This document provides an agenda for the FCS Connect webinar series taking place between October 2022 and May 2023. The February webinar will focus on connecting community and health, discussing topics like the social ecological model, program to policy, systems, and environmental changes (PSE), education, water access in schools, the built environment and physical activity, and interventions to promote walking. The webinar series aims to energize Family and Consumer Sciences programs through sharing latest trends, understanding dietary guidelines, and bridging digital and physical experiences. The final webinar in May will recap the FCS Connect series.
This document contains the schedule and summaries for the FCS Connect program from October 2020 to May 2021. It lists the date, topic, and presenters for each session. The January 2021 session focuses on latest trends in consumer economics presented by Dr. Berry and Dr. Sneed. The document concludes with a request for participants to evaluate the FCS Connect program.
On My Own is a comprehensive financial program for youth that is typically guided through in-person simulations. This is an online-only version created to meet the need of virtual learning in 2020.
The document summarizes a Monday Meetup focused on walking initiatives supported by TNCEP. It discusses starting walking programs in communities and how TNCEP agents can assist. Speakers shared experiences launching walking trails in Coffee and Pickett Counties. They emphasized partnering with groups, creating safe routes, and programming to engage families. Proper evaluation was stressed to track outcomes like physical activity levels and report impacts to funders. Attendees learned how monitoring progress and collecting data on participants, reach, and environmental changes helps assess the value of their work.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
TRAINING 2 Unpacking Tennessee Adolescent Substance Misuse Data
1.
2. PROMPT TN Webinar Series:
Using Data for Action:
What you need to know!
Module 2: Unpacking Tennessee
Adolescent Substance Misuse Data.
3. Learning Objectives
Participants will:
• Better understand the prevalence of substance misuse
among adolescents in TN.
• Describe risk and protective factors for substance misuse.
• Know where to find data.
• Identify ways they can make a difference in their day to
day work.
4. Opioid – Natural, synthetic, or semi-synthetic chemicals that interact with opioid receptors on nerve cells in the
body and brain, and reduce the intensity of pain signals and feelings of pain.
Opioid analgesics – Commonly referred to as prescription opioids, medications that have been used to treat
moderate to severe pain in some patients. Categories of opioids for mortality data include:
Natural opioid analgesics, including morphine and codeine;
Semi-synthetic opioid analgesics, including drugs such as oxycodone, hydrocodone, hydromorphone, and
oxymorphone;
Methadone, a synthetic opioid that can be prescribed for pain reduction or for use in MAT for opioid use
disorder (OUD). For MAT, methadone is used under direct supervision of a healthcare provider;
Synthetic opioid analgesics other than methadone, including drugs such as tramadol and fentanyl.
Illicit drugs – The nonmedical use of a variety of drugs that are prohibited by law. These drugs can include:
amphetamine- type stimulants, marijuana/cannabis, cocaine, heroin, other opioids, and synthetic drugs, such as
illicitly manufactured fentanyl (IMF) and ecstasy (MDMA).
Overdose – Injury to the body (poisoning) that happens when a drug is taken in excessive amounts. An overdose
can be fatal or nonfatal.
Commonly Used Terms
https://www.cdc.gov/drugoverdose/opioids/terms.html
6. National Trends in Youth Risk Behaviors
The Youth Risk Behavior Survey Data Summary &Trends Report:
2009–2019 provides the most recent surveillance data on
on health behaviors and experiences among high school
students in the US related to four priority areas associated
with sexually transmitted diseases (STDs), including HIV, and
unintended teen pregnancy:
• Sexual Behavior,
• High-Risk Substance Use,
• ExperiencingViolence, and
• Mental Health and Suicide.
https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-
508.pdf
7. 2019 YRBS Key Findings
In a number of areas,
particularly
regarding sexual
behavior and high-
risk substance use,
trends over time are
improving
and moving in the
right direction.
https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-
508.pdf
10. On the other hand, experiences of
violence, such as bullying (both
electronically and at school) and
forced sex, remain high among
youth, and trends in these
experiences also remain flat. More
can be done to create safe
environments for youth.
2019 YRBS Key Findings : Experiencing Violence
https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-
508.pdf
11. 2019 YRBS Key Findings: Mental Health and Suicide
https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-
508.pdf
12. YRBS Key Findings :
Sexual Minority
Youth
https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-
508.pdf
13.
14. TN TOGETHER Survey: 2018/2019
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-
2019_TN_Together_Report.pdf
15. Tennessee Youth and
TN TOGETHER Survey Results
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-
2019_TN_Together_Report.pdf
16. TN Together 2018/2019 Prescription Drugs
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-
2019_TN_Together_Report.pdf
17. TN Together 2018/2019: Marijuana
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-
2019_TN_Together_Report.pdf
18. TN Together 2018/2019 Alcohol
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-
2019_TN_Together_Report.pdf
19. TN Together 2018/2019:
Tobacco and Electronic Cigarettes
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-
2019_TN_Together_Report.pdf
23. Adolescent Data Resources
2019 Youth Risk Behavior Survey (YRBS)
National Survey on Drug Use and Health: Trends in Adolescent Substance Use and Perception of Risk From Substance Use
2018-2019 TN TOGETHER Student Survey Results
TN Drug Overdose Dashboard
CDC Healthy Youth
24. Questions?
Post in chat.
Don’t miss the next module in the PROMPT TN Education Series:
A Guide to Addressing Substance Misuse in Your Community
March 24th at 1:00 p.m. EST/12:00 p.m.
Editor's Notes
Lisa will provide an overview of PROMPT TN
How adolescents differ from adults.
While the title indicates a focus on TN data, would a national lens to start be helpful?
https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm#anchor_1612893966
https://www.cdc.gov/mmwr/volumes/69/su/su6901a5.htm
https://www.cdc.gov/healthyyouth/substance-use/index.htm -- Screenshot of “The Facts” ?
https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm#init – Initiation by age group per NSDUH
TN Youth Data : Prevalence
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-2019_TN_Together_Report.pdf
https://www.tn.gov/content/dam/tn/mentalhealth/documents/2018-2019_TN_Together_Onepagers.pdf
Links to TN Together Survey for 2018-2019 report and one-pagers.
AND/OR
https://www.tn.gov/content/tn/behavioral-health/research/data--research--and-planning/behavioral-health-indicators-for-tennessee-and-the-u-s-.html
2018 TN Data Book
Select screenshots from prescription drugs one-pager or https://www.tn.gov/behavioral-health/substance-abuse-services/prevention/tn-together-student-survey.html?
Select screenshots from marijuana one-pager or https://www.tn.gov/behavioral-health/substance-abuse-services/prevention/tn-together-student-survey.html ?
Select screenshots from alcohol one-pager or https://www.tn.gov/behavioral-health/substance-abuse-services/prevention/tn-together-student-survey.html ?
Select screenshots from tobacco one-pager or https://www.tn.gov/behavioral-health/substance-abuse-services/prevention/tn-together-student-survey.html ?